Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$193 Mln
Revenue (TTM)
$322 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.7 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
4
Industry P/E
26.59
EV/EBITDA
103.4
Div. Yield
0 %
Debt to Equity
12
Book Value
$--
EPS
$-0.3
Face value
--
Shares outstanding
125,994,000
CFO
$-124.81 Mln
EBITDA
$-149.83 Mln
Net Profit
$-462.13 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Beauty Health Co (SKIN)
| -8.2 | -16.1 | 10.6 | -19.8 | -49.3 | -- | -- |
|
BSE Sensex*
| 5.3 | 0.4 | 9.2 | 6.6 | 17.1 | 18.9 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Beauty Health Co (SKIN)
| -48.6 | -65.8 | -62.3 | 113.6 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Beauty Health Co (SKIN)
|
1.5 | 192.8 | 322.5 | -38.5 | -5.0 | -72.8 | -- | 4.0 |
| 4.8 | 4,309.1 | 6,003.9 | -396.0 | -2.2 | -10.6 | -- | 1.2 | |
| 23.0 | 1,071.8 | 2,224.5 | 84.7 | 12.6 | 5.5 | 13.3 | 0.7 | |
| 132.8 | 4,347.3 | 1,467.2 | 234.9 | 18.9 | 24.9 | 26.2 | 5.4 | |
| 7.7 | 392.8 | 1,679.3 | -38.6 | -1.1 | -5.3 | -- | 0.5 | |
| 56.3 | 847.3 | 474.1 | 49.5 | 10.7 | 21 | 17 | 3.3 | |
| 1.4 | 958.9 | 420.7 | 12.2 | 19.0 | 1.4 | 72 | 1.1 | |
| 0.6 | 4.6 | 4.8 | 0.0 | -8.6 | -151.6 | -- | 0.0 | |
| 0.6 | 88.5 | 10.6 | -36.4 | -272.4 | -136.2 | -- | 4.0 | |
| 243.5 | 3,311.9 | 610.6 | 85.4 | 16.3 | 36.1 | 38.9 | 13.6 |
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product... is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California. Address: 2165 Spring Street, Long Beach, CA, United States, 90806 Read more
President, CEO & Director
Ms. Marla Malcolm Beck
President, CEO & Director
Ms. Marla Malcolm Beck
Headquarters
Long Beach, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Beauty Health Co (SKIN) stood at $ 737 Mln as on 31-Mar-25
The share price of Beauty Health Co (SKIN) is $1.46 (NASDAQ) as of 18-Jun-2025 16:00 EDT. Beauty Health Co (SKIN) has given a return of -49.34% in the last 3 years.
Beauty Health Co (SKIN) has a market capitalisation of $ 193 Mln as on 18-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Beauty Health Co (SKIN) is 3.99 times as on 18-Jun-2025, a 46% discount to its peers’ median range of 7.33 times.
Since, TTM earnings of Beauty Health Co (SKIN) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Beauty Health Co (SKIN) and enter the required number of quantities and click on buy to purchase the shares of Beauty Health Co (SKIN).
The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California. Address: 2165 Spring Street, Long Beach, CA, United States, 90806
The CEO & director of Ms. Marla Malcolm Beck. is Beauty Health Co (SKIN), and CFO & Sr. VP is Ms. Marla Malcolm Beck.
There is no promoter pledging in Beauty Health Co (SKIN).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
452
|
|
|
442
|
|
|
330
|
|
|
119
|
|
|
89
|
|
|
83
|
|
|
40
|
|
|
10
|
|
|
0
|
| Beauty Health Co (SKIN) | Ratios |
|---|---|
|
Return on equity(%)
|
-72.82
|
|
Operating margin(%)
|
-5.05
|
|
Net Margin(%)
|
-11.94
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Beauty Health Co (SKIN) was $0 Mln.
$-0.07
(
